Parenteral Drugs (India) Ltd Peer Comparison
PDPL · Healthcare · Current price ₹4.25
Peers tracked
11
Parenteral Drugs (India) Ltd P/E
—
Sector
Healthcare
Parenteral Drugs (India) Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Covance Softsol Ltd | — | 36.9x | 317 |
| Speciality Medicines Ltd | — | 11.0x | 149 |
| Himalaya Nutravedics India Ltd | — | — | 132 |
| Cian Healthcare Ltd | — | — | 70 |
| Natco Pharma Limited-RE | ₹25.85 | — | 44 |
| Parmax Pharma Ltd | — | -40.7x | 38 |
| Medico Intercontinental Ltd | — | 36.9x | 25 |
| Sat Kartar Life Ltd | — | 12.1x | 20 |
| Parenteral Drugs (India) Ltd | ₹4.25 | — | 12 |
| Spectra Industries Ltd | — | -1.2x | 3 |
| Cresanto Global Limited | — | -5.5x | 2 |
Parenteral Drugs (India) Ltd versus its peers
Parenteral Drugs (India) Ltd operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of — may be cheap in one industry and expensive in another.
More on Parenteral Drugs (India) Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.